| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACCELERATE DIAGNOSTICS INC | 5,037,747 | 72,392,000 | 18.82% | ||
| 2 | QUIDEL CORP COM | 2,573,554 | 44,420,000 | 11.55% | ||
| 3 | OPKO HEALTH INC | 3,914,000 | 40,666,000 | 10.57% | ||
| 4 | NXSTAGE MED INC COM | 2,694,636 | 40,393,000 | 10.50% | ||
| 5 | MAZOR ROBOTICS LTD | 2,909,566 | 36,195,000 | 9.41% | ||
| 6 | TESARO INC | 640,966 | 28,222,000 | 7.34% | ||
| 7 | PACIFIC BIOSCIENCES CALIF IN | 3,312,089 | 26,610,000 | 6.92% | ||
| 8 | ACCURAY INCORPORATED COM | 2,553,218 | 14,758,000 | 3.84% | ||
| 9 | BIOLASE INC | 10,529,525 | 13,794,000 | 3.59% | ||
| 10 | INTREXON CORP | 403,729 | 13,682,000 | 3.56% | ||
| 11 | VERMILLION INC | 8,624,225 | 12,678,000 | 3.30% | ||
| 12 | HANSEN MEDICAL INC | 4,491,820 | 11,702,000 | 3.04% | ||
| 13 | AMARIN CORP PLC | 5,818,805 | 8,903,000 | 2.32% | ||
| 14 | AGENUS INC | 1,882,477 | 7,831,000 | 2.04% | ||
| 15 | TRANSITION THERAPEUTICS INC | 3,817,972 | 4,887,000 | 1.27% | ||
| 16 | CONTRAFECT CORP COM | 1,182,032 | 4,019,000 | 1.05% | ||
| 17 | BIOGEN INC | 6,723 | 1,750,000 | 0.46% | ||
| 18 | METABOLIX INC RESTRICTED | 726,935 | 1,381,000 | 0.36% | ||
| 19 | SECOND SIGHT MED PRODS INC COM | 50,804 | 245,000 | 0.06% | ||
| 20 | ZIOPHARM ONCOLOGY INC | 6,661 | 49,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001085146-16-004350, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
